PI3K and cancer metabolism

被引：0
|
作者：
Cantley, Lewis C. [1 ]
机构：
[1] Cornell Univ, Weill Cornell Med Coll, New York, NY 10021 USA
来源：
CANCER RESEARCH | 2013年 / 73卷
关键词：
D O I：
10.1158/1538-7445.FBCR13-IA22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA22
引用
收藏
页数：2
相关论文
共 50 条
  • [31] New roles for PI3K isoforms in cancer
    Vanhaesebroeck, Bart
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07)
  • [32] Nuclear PI3K signalling in colorectal cancer
    Palmieri, M.
    Catimel, B.
    Holmes, A.
    Sieber, O.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S123 - S123
  • [33] Development and safety of PI3K inhibitors in cancer
    Miaomiao Yu
    Jiajia Chen
    Zhifei Xu
    Bo Yang
    Qiaojun He
    Peihua Luo
    Hao Yan
    Xiaochun Yang
    Archives of Toxicology, 2023, 97 : 635 - 650
  • [34] Oncogenic PI3K and its role in cancer
    Samuels, Y
    Ericson, K
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (01) : 77 - 82
  • [35] Prostate cancer, PI3K, PTEN and prognosis
    Wise, Helen M.
    Hermida, Miguel A.
    Leslie, Nicholas R.
    CLINICAL SCIENCE, 2017, 131 (03) : 197 - 210
  • [36] Targeting RAS and PI3K in lung cancer
    Julian Downward
    Nature Medicine, 2008, 14 : 1315 - 1316
  • [37] PI3K and cancer: lessons, challenges and opportunities
    Fruman, David A.
    Rommel, Christian
    NATURE REVIEWS DRUG DISCOVERY, 2014, 13 (02) : 140 - 156
  • [38] PI3Kδ REGULATES IMMUNE TOLERANCE TO CANCER
    不详
    CANCER DISCOVERY, 2014, 4 (08) : 865 - 865
  • [39] First PI3K Inhibitor for Breast Cancer
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (01): : 19 - 19
  • [40] PI3K: A potential therapeutic target for cancer
    Chen, Yingwei
    Wang, Bao-Can
    Xiao, Yongtao
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (07) : 2818 - 2821
12345